京新藥業(002020.SZ):2個藥品擬中選第三批全國藥品集中採購
格隆匯8月20日丨京新藥業(002020.SZ)公佈,2020年8月20日,公司參加了國家組織藥品集中採購和使用聯合採購辦公室組織實施的第三批國家組織藥品集中採購的招投標。公司已通過仿製藥質量和療效一致性評價的藥品鹽酸舍曲林片、匹伐他汀鈣分散片在本次招投標中擬中選。
本次鹽酸舍曲林片擬中選企業為2家,匹伐他汀鈣片(分散片)擬中選企業為4家,根據聯合採購辦公室發佈的《全國藥品集中採購文件(GY-YD2020-1)》文件:全國實際中選企業數為2家的,為首年約定採購量計算基數的60%;全國實際中選企業數為4家及以上的,為首年約定採購量計算基數的80%。全國實際中選企業數為1家或2家的,本輪採購週期原則上為1年;全國實際中選企業數為4家及以上的,本輪採購週期原則上為3年。採購週期內採購協議每年一簽。續簽採購協議時,約定採購量原則上不少於各地該中選藥品上年約定採購量。採購週期內若提前完成當年約定採購量,超出部分中選企業仍按中選價進行供應,直至採購週期屆滿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.